MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, NERV has $94,027,156 in assets. $343,079,094 in debts. $32,659,770 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1764.91%
Quick Ratio
1764.91%
Cash Ratio
728.66%
Debt to Asset Ratio
364.87%
Unit: Dollar
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Goodwill
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Warrant liability
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
32,659,770 82,301,813 12,286,646 15,247,910
Marketable securities
45,405,126 ---
Restricted cash
100,000 100,000 100,000 100,000
Prepaid expenses and other current assets
941,883 697,676 633,533 199,615
Total current assets
79,106,779 83,099,489 13,020,179 15,547,525
Equipment, net
-0 1,360 2,721
Goodwill
14,869,399 14,869,399 14,869,399 14,869,399
Deferred offering costs
50,978 -201,114 -
Total assets
94,027,156 97,968,888 28,092,052 30,419,645
Accounts payable
2,118,225 639,707 944,492 896,799
Accrued expenses and other current liabilities
2,363,968 1,650,766 1,727,830 1,632,059
Total current liabilities
4,482,193 2,290,473 2,672,322 2,528,858
Warrant liability
278,596,901 171,464,575 --
Liability related to the sale of future royalties
60,000,000 60,000,000 60,000,000 60,000,000
Total liabilities
343,079,094 233,755,048 62,672,322 62,528,858
Series a convertible preferred stock 0.0001 par value 200,000 shares authorized 3,296 issued and outstanding liquidation preference of 0 as of march 31, 2026 and december 31, 2025
4,961,922 4,961,922 --
Common stock 0.0001 par value 250,000,000 shares authorized 43,841,998 shares issued and outstanding as of march 31, 2026 and 43,274,398 shares issued and outstanding as of december 31, 2025
4,384 4,327 699 699
Additional paid-in capital
560,185,880 548,047,331 370,551,108 370,278,211
Accumulated deficit
-814,204,124 -688,799,740 -405,132,077 -402,388,123
Total stockholders' deficit
-254,013,860 -140,748,082 -34,580,270 -32,109,213
Total liabilities, redeemable preferred stock and stockholders' deficit
94,027,156 97,968,888 28,092,052 30,419,645
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$45,405,126 Cash and cashequivalents$32,659,770 Prepaid expenses andother current assets$941,883 Restricted cash$100,000 Total current assets$79,106,779 Goodwill$14,869,399 Deferred offering costs$50,978 Total assets$94,027,156 Accumulated deficit-$814,204,124 Total liabilities,redeemable preferred stock...$94,027,156 Total stockholders'deficit-$254,013,860 Additional paid-in capital$560,185,880 Common stock 0.0001 parvalue 250,000,000...$4,384 Total liabilities$343,079,094 Series a convertiblepreferred stock 0.0001 par...$4,961,922 Warrant liability$278,596,901 Liability related to thesale of future...$60,000,000 Total currentliabilities$4,482,193 Accrued expenses andother current...$2,363,968 Accounts payable$2,118,225